To evaluate a deep learning model's ability to identify acromegaly from hand photographs while maintaining patient privacy, which is crucial for ethical medical practices.
Key Findings:
The model achieved 89% sensitivity and 91% specificity, with an F1 score of 0.89 and AUROC of 0.96, showing consistent performance across age, remission status, and sex.
It outperformed 10 board-certified endocrinologists, whose F1 scores ranged from 0.43 to 0.63, with subgroup analyses indicating sensitivity and specificity of 89% and 90% in younger patients and 86% and 95% in older patients.
Interpretation:
The deep learning model demonstrates significant potential for accurate acromegaly detection based on external physical traits, aiding healthcare providers without specialized training.
Limitations:
Incomplete biochemical confirmation in some control participants may affect the reliability of results.
Higher prevalence of acromegaly than in general practice limits generalizability.
Study limited to Japanese patients from specialist centers may not reflect broader populations.
Conclusion:
The study highlights the promise of AI in enhancing diagnostic accuracy for acromegaly while preserving patient anonymity, potentially improving healthcare delivery.
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.